Growth Factor interactions in bone regeneration

Tissue Engineering - Part B: Reviews

Volumn 16, Issue 6, 2010, Pages 551-566

  Kempen, Diederik H R ^a   Creemers, Laura B ^a   Alblas, Jacqueline ^a   Lu, Lichun ^b   Verbout, Abraham J ^a   Yaszemski, Michael J ^b   Dhert, Wouter J A ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Mayo Clinic   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVE MOLECULES; BONE FORMATION; BONE HEALING; BONE REGENERATION; COMPLEX PROCESSES; CYTOKINES; GROWTH FACTOR; IN-VIVO; NATURAL PROCESS; REGENERATION PROCESS;

DRUG THERAPY; PEPTIDES;

BONE;

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CYTOKINE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 9; GROWTH FACTOR; INTERLEUKIN 11; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANGIOGENESIS; ARTICLE; BONE REGENERATION; CELL DIFFERENTIATION; CELL MIGRATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; GENE THERAPY; GENETIC TRANSCRIPTION; MESENCHYME CELL; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN SECRETION; UPREGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CYTOKINES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;

EID: 78649861129     PISSN: 19373368     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.teb.2010.0176     Document Type: Article

References (169)

1. Giannoudis, P.V., Dinopoulos, H., and Tsiridis, E. Bone substitutes: an update. Injury 36 Suppl 3, S20, 2005.
2. Buck, B.E., Malinin, T.I., and Brown, M.D. Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop Relat Res 240, 129, 1989.
3. Younger, E.M., and Chapman, M.W. Morbidity at bone graft donor sites. J Orthop Trauma 3, 192, 1989.
4. Arrington, E.D., Smith, W.J., Chambers, H.G., Bucknell, A.L., and Davino, N.A. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 329, 300, 1996.
5. Norman-Taylor, F.H., and Villar, R.N. Bone allograft: a cause for concern? J Bone Joint Surg Br 79, 178, 1997.
6. Silber, J.S., Anderson, D.G., Daffner, S.D., Brislin, B.T., Le-land, J.M., Hilibrand, A.S., Vaccaro, A.R., and Albert, T.J. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 28, 134, 2003.
7. Urist, M.R. Bone: formation by autoinduction. Science 150, 893, 1965.
8. Urist, M.R., Iwata, H., Ceccotti, P.L., Dorfman, R.L., Boyd, S.D., McDowell, R.M., and Chien, C. Bone morphogenesis in implants of insoluble bone gelatin. Proc Natl Acad Sci USA 70, 3511, 1973.
9. Riley, E.H., Lane, J.M., Urist, M.R., Lyons, K.M., and Lie-berman, J.R. Bone morphogenetic protein-2: biology and applications. Clin Orthop Relat Res 324, 39, 1996.
10. Rengachary, S.S. Bone morphogenetic proteins: basic concepts. Neurosurg Focus 13, e2, 2002.
11. Wozney, J.M. Overview of bone morphogenetic proteins. Spine 27, S2, 2002.
12. Aoki, H., Fujii, M., Imamura, T., Yagi, K., Takehara, K., Kato, M., and Miyazono, K. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci 114, 1483, 2001.
13. Hazama, M., Aono, A., Ueno, N., and Fujisawa, Y. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system. Biochem Biophys Res Commun 209, 859, 1995.
14. Sampath, T.K., Coughlin, J.E., Whetstone, R.M., Banach, D., Corbett, C., Ridge, R.J., Ozkaynak, E., Oppermann, H., and Rueger, D.C. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem 265, 13198, 1990.
15. Canalis, E., Economides, A.N., and Gazzerro, E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24, 218, 2003.
16. Wang, E.A., Rosen, V., Cordes, P., Hewick, R.M., Kriz, M.J., Luxenberg, D.P., Sibley, B.S., and Wozney, J.M. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 85, 9484, 1988.
17. Cheng, H., Jiang, W., Phillips, F.M., Haydon, R.C., Peng, Y., Zhou, L., Luu, H.H., An, N., Breyer, B., Vanichakarn, P., Szatkowski, J.P., Park, J.Y., and He, T.C. Osteogenic activity of the fourteen types of human bone morphoge-netic proteins (BMPs). J Bone Joint Surg Am 85-A, 1544, 2003.
18. Luu, H.H., Song, W.X., Luo, X., Manning, D., Luo, J., Deng, Z.L., Sharff, K.A., Montag, A.G., Haydon, R.C., and He, T.C. Distinct roles of bone morphogenetic proteins in os-teogenic differentiation of mesenchymal stem cells. J Or-thop Res 25, 665, 2007.
19. Wang, E.A., Rosen, V., D'Alessandro, J.S., Bauduy, M., Cordes, P., Harada, T., Israel, D.I., Hewick, R.M., Kerns, K.M., LaPan, P., et al. Recombinant human bone morpho-genetic protein induces bone formation. Proc Natl Acad Sci USA 87, 2220, 1990.
20. Niikura, T., Hak, D.J., and Reddi, A.H. Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures. J Orthop Res 24, 1463, 2006.
21. Zhu, W., Rawlins, B.A., Boachie-Adjei, O., Myers, E.R., Ar-imizu, J., Choi, E., Lieberman, J.R., Crystal, R.G., and Hi-daka, C. Combined bone morphogenetic protein-2 and-7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res 19, 2021, 2004.
22. Cho, T.J., Gerstenfeld, L.C., and Einhorn, T.A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17, 513, 2002.
23. Ripamonti, U., Crooks, J., Petit, J.C., and Rueger, D.C. Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein-1 and bone morphogenetic protein-2. A pilot study in Chacma baboons (Papio ursinus). Eur J Oral Sci 109, 241, 2001.
24. Israel, D.I., Nove, J., Kerns, K.M., Kaufman, R.J., Rosen, V., Cox, K.A., and Wozney, J.M. Heterodimeric bone mor-phogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13, 291, 1996.
25. Aono, A., Hazama, M., Notoya, K., Taketomi, S., Yamasaki, H., Tsukuda, R., Sasaki, S., and Fujisawa, Y. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun 210, 670, 1995.
26. Koh, J.T., Zhao, Z., Wang, Z., Lewis, I.S., Krebsbach, P.H., and Franceschi, R.T. Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration. J Dent Res 87, 845, 2008.
27. Zhao, M., Zhao, Z., Koh, J.T., Jin, T., and Franceschi, R.T. Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J Cell Biochem 95, 1, 2005.
28. Kawai, M., Bessho, K., Maruyama, H., Miyazaki, J., and Yamamoto, T. Simultaneous gene transfer of bone mor-phogenetic protein (BMP)-2 and BMP-7 by in vivo elec-troporation induces rapid bone formation and BMP-4 expression. BMC Musculoskelet Disord 7, 62, 2006.
29. Miyazono, K., Maeda, S., and Imamura, T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16, 251, 2005.
30. Yanagita, M. BMP antagonists: Their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev 16, 309, 2005.
31. Wrana, J.L., and Attisano, L. The Smad pathway. Cytokine Growth Factor Rev 11, 5, 2000.
32. Rosen, V., Thies, R.S., and Lyons, K. Signaling pathways in skeletal formation: a role for BMP receptors. Ann N Y Acad Sci 785, 59, 1996.
33. Ten Dijke, P., Yamashita, H., Sampath, T.K., Reddi, A.H., Estevez, M., Riddle, D.L., Ichijo, H., Heldin, C.H., and Miyazono, K. Identification of type I receptors for osteo-genic protein-1 and bone morphogenetic protein-4. J Biol Chem 269, 16985, 1994.
34. Ebisawa, T., Tada, K., Kitajima, I., Tojo, K., Sampath, T.K., Kawabata, M., Miyazono, K., and Imamura, T. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci 112 (Pt 20), 3519, 1999.
35. Macias-Silva, M., Hoodless, P.A., Tang, S.J., Buchwald, M., and Wrana, J.L. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 273, 25628, 1998.
36. Tsumaki, N., and Yoshikawa, H. The role of bone mor-phogenetic proteins in endochondral bone formation. Cy-tokine Growth Factor Rev 16, 279, 2005.
37. Zhu, W., Kim, J., Cheng, C., Rawlins, B.A., Boachie-Adjei, O., Crystal, R.G., and Hidaka, C. Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. Bone 39, 61, 2006.
38. Lawrence, D.A. Latent-TGF-beta: an overview. Mol Cell Biochem 219, 163, 2001.
39. Annes, J.P., Munger, J.S., and Rifkin, D.B. Making sense of latent TGFbeta activation. J Cell Sci 116, 217, 2003.
40. Janssens, K., ten Dijke, P., Janssens, S., and Van Hul, W. Transforming growth factor-beta1 to the bone. Endocr Rev 26, 743, 2005.
41. Bostrom, M.P., and Asnis, P. Transforming growth factor beta in fracture repair. Clin Orthop Relat Res 355 Suppl, S124, 1998.
42. Duneas, N., Crooks, J., and Ripamonti, U. Transforming growth factor-beta 1: induction of bone morphogenetic protein genes expression during endochondral bone formation in the baboon, and synergistic interaction with os-teogenic protein-1 (BMP-7). Growth Factors 15, 259, 1998.
43. Ripamonti, U., Duneas, N., Van Den Heever, B., Bosch, C., and Crooks, J. Recombinant transforming growth factor-beta1 induces endochondral bone in the baboon and sy-nergizes with recombinant osteogenic protein-1 (bone morphogenetic protein-7) to initiate rapid bone formation. J Bone Miner Res 12, 1584, 1997.
44. Bentz, H., Nathan, R.M., Rosen, D.M., Armstrong, R.M., Thompson, A.Y., Segarini, P.R., Mathews, M.C., Dasch, J.R., Piez, K.A., and Seyedin, S.M. Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem 264, 20805, 1989.
45. Bentz, H., Thompson, A.Y., Armstrong, R., Chang, R.J., Piez, K.A., and Rosen, D.M. Transforming growth factor-beta 2 enhances the osteoinductive activity of a bovine bone-derived fraction containing bone morphogenetic protein-2 and 3. Matrix 11, 269, 1991.
46. Heckman, J.D., Ehler, W., Brooks, B.P., Aufdemorte, T.B., Lohmann, C.H., Morgan, T., and Boyan, B.D. Bone mor-phogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer. J Bone Joint Surg Am 81, 1717, 1999.
47. Oest, M.E., Dupont, K.M., Kong, H.-J., Mooney, D.J., and Guldberg, R.E. Delivery of BMP-2 & TGF-beta3 additively enhance functional repair of segmental defects. Proceedings of the 53rd Meeting of the Orthopedic Research Society, San Diego, CA, February 10-14, 2007.
48. Si, X., Jin, Y., and Yang, L. Induction of new bone by ceramic bovine bone with recombinant human bone mor-phogenetic protein 2 and transforming growth factor beta. Int J Oral Maxillofac Surg 27, 310, 1998.
49. Simmons, C.A., Alsberg, E., Hsiong, S., Kim, W.J., and Mooney, D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35, 562, 2004.
50. Sumner, D.R., Turner, T.M., Urban, R.M., Virdi, A.S., and Inoue, N. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model. J Bone Joint Surg Am 88, 806, 2006.
51. Otsuru, S., Tamai, K., Yamazaki, T., Yoshikawa, H., and Kaneda, Y. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun 354, 453, 2007.
52. Ramoshebi, L.N., and Ripamonti, U. Osteogenic protein-1, a bone morphogenetic protein, induces angiogenesis in the chick chorioallantoic membrane and synergizes with basic fibroblast growth factor and transforming growth factor-beta1. Anat Rec 259, 97, 2000.
53. Fromigue, O., Marie, P.J., and Lomri, A. Bone morphoge-netic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 68, 411, 1998.
54. Eswarakumar, V.P., Lax, I., and Schlessinger, J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16, 139, 2005.
55. Schmid, G.J., Kobayashi, C., Sandell, L.J., and Ornitz, D.M. Fibroblast growth factor expression during skeletal fracture healing in mice. Dev Dyn 238, 766, 2009.
56. Bourque, W.T., Gross, M., and Hall, B.K. Expression of four growth factors during fracture repair. Int J Dev Biol 37, 573, 1993.
57. Marie, P.J. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316, 23, 2003.
58. Kato, T., Kawaguchi, H., Hanada, K., Aoyama, I., Hiyama, Y., Nakamura, T., Kuzutani, K., Tamura, M., Kurokawa, T., and Nakamura, K. Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J Orthop Res 16, 654, 1998.
59. Kawaguchi, H., Kurokawa, T., Hanada, K., Hiyama, Y., Tamura, M., Ogata, E., and Matsumoto, T. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135, 774, 1994.
60. Nakamura, T., Hara, Y., Tagawa, M., Tamura, M., Yuge, T., Fukuda, H., and Nigi, H. Recombinant human basic fi-broblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 13, 942, 1998.
61. Okazaki, H., Kurokawa, T., Nakamura, K., Matsushita, T., Mamada, K., and Kawaguchi, H. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callo-tasis bone lengthening of rabbits. Calcif Tissue Int 64, 542, 1999.
62. Radomsky, M.L., Aufdemorte, T.B., Swain, L.D., Fox, W.C., Spiro, R.C., and Poser, J.W. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res 17, 607, 1999.
63. Radomsky, M.L., Thompson, A.Y., Spiro, R.C., and Poser, J.W. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop Relat Res 355 Suppl, S283, 1998.
64. Nakajima, F., Ogasawara, A., Goto, K., Moriya, H., Nino-miya, Y., Einhorn, T.A., and Yamazaki, M. Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factor. J Orthop Res 19, 935, 2001.
65. Kubota, K., Iseki, S., Kuroda, S., Oida, S., Iimura, T., Duarte, W.R., Ohya, K., Ishikawa, I., and Kasugai, S. Sy-nergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone 31, 465, 2002.
66. Fujimura, K., Bessho, K., Okubo, Y., Kusumoto, K., Segami, N., and Iizuka, T. The effect of fibroblast growth factor-2 on the osteoinductive activity of recombinant human bone morphogenetic protein-2 in rat muscle. Arch Oral Biol 47, 577, 2002.
67. Kakudo, N., Kusumoto, K., Kuro, A., and Ogawa, Y. Effect of recombinant human fibroblast growth factor-2 on intramuscular ectopic osteoinduction by recombinant human bone morphogenetic protein-2 in rats. Wound Repair Re-gen 14, 336, 2006.
68. Nakamura, Y., Tensho, K., Nakaya, H., Nawata, M., Okabe, T., and Wakitani, S. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 36, 399, 2005.
69. Tanaka, E., Ishino, Y., Sasaki, A., Hasegawa, T., Watanabe, M., Dalla-Bona, D.A., Yamano, E., Van Eijden, T.M., and Tanne, K. Fibroblast growth factor-2 augments recombi-nant human bone morphogenetic protein-2-induced os-teoinductive activity. Ann Biomed Eng 34, 717, 2006.
70. Hanada, K., Dennis, J.E., and Caplan, A.I. Stimulatory effects of basic fibroblast growth factor and bone morpho-genetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 12, 1606, 1997.
71. Fakhry, A., Ratisoontorn, C., Vedhachalam, C., Salhab, I., Koyama, E., Leboy, P., Pacifici, M., Kirschner, R.E., and Nah, H.D. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36, 254, 2005.
72. Martin, I., Muraglia, A., Campanile, G., Cancedda, R., and Quarto, R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138, 4456, 1997.
73. Quarto, N., and Longaker, M.T. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 12, 1405, 2006.
74. Varkey, M., Kucharski, C., Haque, T., Sebald, W., and Uludag, H. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clin Orthop Relat Res 443, 113, 2006.
75. Singhatanadgit, W., Salih, V., and Olsen, I. Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions. J Cell Physiol 209, 912, 2006.
76. Conover, C.A. Insulin-like growth factor-binding proteins and bone metabolism. Am J Physiol Endocrinol Metab 294, E10, 2008.
77. Niu, T., and Rosen, C.J. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 361, 38, 2005.
78. Rosen, C.J. Insulin-like growth factor I and bone mineral density: experience from animal models and human observational studies. Best Pract Res Clin Endocrinol Metab 18, 423, 2004.
79. Geusens, P.P., and Boonen, S. Osteoporosis and the growth hormone-insulin-like growth factor axis. Horm Res 58 Suppl 3, 49, 2002.
80. Fowlkes, J.L., Thrailkill, K.M., Liu, L., Wahl, E.C., Bunn, R.C., Cockrell, G.E., Perrien, D.S., Aronson, J., and Lump-kin, C.K., Jr. Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model. J Bone Miner Res 21, 1359, 2006.
81. Meinel, L., Zoidis, E., Zapf, J., Hassa, P., Hottiger, M.O., Auer, J.A., Schneider, R., Gander, B., Luginbuehl, V., Bettschart-Wolfisberger, R., Illi, O.E., Merkle, H.P., and Von Rechenberg, B. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 33, 660, 2003.
82. Raiche, A.T., and Puleo, D.A. In vitro effects of combined and sequential delivery of two bone growth factors. Bio-materials 25, 677, 2004.
83. Yeh, L.C., Adamo, M.L., Olson, M.S., and Lee, J.C. Osteo-genic protein-1 and insulin-like growth factor I synergisti-cally stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 138, 4181, 1997.
84. Lan, J., Wang, Z., Wang, Y., Wang, J., and Cheng, X. The effect of combination of recombinant human bone mor-phogenetic protein-2 and basic fibroblast growth factor or insulin-like growth factor-I on dental implant osseointe-gration by confocal laser scanning microscopy. J Period-ontol 77, 357, 2006.
85. Blumenfeld, I., Srouji, S., Lanir, Y., Laufer, D., and Livne, E. Enhancement of bone defect healing in old rats by TGF-beta and IGF-1. Exp Gerontol 37, 553, 2002.
86. Srouji, S., Blumenfeld, I., Rachmiel, A., and Livne, E. Bone defect repair in rat tibia by TGF-beta1 and IGF-1 released from hydrogel scaffold. Cell Tissue Bank 5, 223, 2004.
87. Srouji, S., Rachmiel, A., Blumenfeld, I., and Livne, E. Mandibular defect repair by TGF-beta and IGF-1 released from a biodegradable osteoconductive hydrogel. J Cranio-maxillofac Surg 33, 79, 2005.
88. Schmidmaier, G., Wildemann, B., Gabelein, T., Heeger, J., Kandziora, F., Haas, N.P., and Raschke, M. Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1. Acta Orthop Scand 74, 604, 2003.
89. Kveiborg, M., Flyvbjerg, A., Eriksen, E.F., and Kassem, M. Transforming growth factor-beta1 stimulates the production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors. J Endocrinol 169, 549, 2001.
90. Okazaki, R., Durham, S.K., Riggs, B.L., and Conover, C.A. Transforming growth factor-beta and forskolin increase all classes of insulin-like growth factor-I transcripts in normal human osteoblast-like cells. Biochem Biophys Res Com-mun 207, 963, 1995.
91. Giannobile, W.V., Whitson, S.W., and Lynch, S.E. Non-coordinate control of bone formation displayed by growth factor combinations with IGF-I. J Dent Res 76, 1569, 1997.
92. Kasperk, C.H., Wergedal, J.E., Mohan, S., Long, D.L., Lau, K.H., and Baylink, D.J. Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Factors 3, 147, 1990.
93. Mott, D.A., Mailhot, J., Cuenin, M.F., Sharawy, M., and Borke, J. Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze-dried bone allograft with specific growth factors. J Oral Implantol 28, 57, 2002.
94. Pfeilschifter, J., Oechsner, M., Naumann, A., Gronwald, R.G., Minne, H.W., and Ziegler, R. Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta. Endocrinology 127, 69, 1990.
95. Gerstenfeld, L.C., Cullinane, D.M., Barnes, G.L., Graves, D.T., and Einhorn, T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88, 873, 2003.
96. Hansen-Algenstaedt, N., Joscheck, C., Wolfram, L., Schae-fer, C., Muller, I., Bottcher, A., Deuretzbacher, G., Wiesner, L., Leunig, M., Algenstaedt, P., and Ruther, W. Sequential changes in vessel formation and micro-vascular function during bone repair. Acta Orthop 77, 429, 2006.
97. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13, 9, 1999.
98. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F.V., Jr., Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J.L., Daugherty, A., Van Bruggen, N., Redmond, H.P., Carano, R.A., and Filvaroff, E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99, 9656, 2002.
99. Eckardt, H., Ding, M., Lind, M., Hansen, E.S., Christensen, K.S., and Hvid, I. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br 87, 1434, 2005.
100. Kaigler, D., Wang, Z., Horger, K., Mooney, D.J., and Krebsbach, P.H. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21, 735, 2006.
101. Peng, H., Usas, A., Olshanski, A., Ho, A.M., Gearhart, B., Cooper, G.M., and Huard, J. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20, 2017, 2005.
102. Kaigler, D., Krebsbach, P.H., West, E.R., Horger, K., Huang, Y.C., and Mooney, D.J. Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J 19, 665, 2005.
103. Wang, D.S., Miura, M., Demura, H., and Sato, K. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 138, 2953, 1997.
104. Deckers, M.M., Van Bezooijen, R.L., Van Der Horst, G., Hoogendam, J., Van Der Bent, C., Papapoulos, S.E., and Lowik, C.W. Bone morphogenetic proteins stimulate an-giogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143, 1545, 2002.
105. Kozawa, O., Matsuno, H., and Uematsu, T. Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts. J Cell Biochem 81, 430, 2001.
106. Yeh, L.C., and Lee, J.C. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrinol 153, 113, 1999.
107. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.C., Cummins, J., and Huard, J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110, 751, 2002.
108. Samee, M., Kasugai, S., Kondo, H., Ohya, K., Shimokawa, H., and Kuroda, S. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 108, 18, 2008.
109. Huang, Y.C., Kaigler, D., Rice, K.G., Krebsbach, P.H., and Mooney, D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20, 848, 2005.
110. Kempen, D.H., Lu, L., Heijink, A., Hefferan, T.E., Creemers, L.B., Maran, A., Yaszemski, M.J., and Dhert, W.J. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30, 2816, 2009.
111. Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M.E., and Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
112. Fiedler, J., Leucht, F., Waltenberger, J., Dehio, C., and Brenner, R.E. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Bio-chem Biophys Res Commun 334, 561, 2005.
113. Fiedler, J., Roderer, G., Gunther, K.P., and Brenner, R.E. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87, 305, 2002.
114. Hollinger, J.O., Hart, C.E., Hirsch, S.N., Lynch, S., and Friedlaender, G.E. Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am 90 Suppl 1, 48, 2008.
115. Greenberg, J.I., Shields, D.J., Barillas, S.G., Acevedo, L.M., Murphy, E., Huang, J., Scheppke, L., Stockmann, C., Johnson, R.S., Angle, N., and Cheresh, D.A. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456, 809, 2008.
116. Zhang, F., Tang, Z., Hou, X., Lennartsson, J., Li, Y., Koch, A.W., Scotney, P., Lee, C., Arjunan, P., Dong, L., Kumar, A., Rissanen, T.T., Wang, B., Nagai, N., Fons, P., Fariss, R., Zhang, Y., Wawrousek, E., Tansey, G., Raber, J., Fong, G.H., Ding, H., Greenberg, D.A., Becker, K.G., Herbert, J.M., Nash, A., Yla-Herttuala, S., Cao, Y., Watts, R.J., and Li, X. VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proc Natl Acad Sci USA 106, 6152, 2009.
117. Marden, L.J., Fan, R.S., Pierce, G.F., Reddi, A.H., and Hollinger, J.O. Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects. J Clin Invest 92, 2897, 1993.
118. Ranly, D.M., McMillan, J., Keller, T., Lohmann, C.H., Meunch, T., Cochran, D.L., Schwartz, Z., and Boyan, B.D. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am 87, 2052, 2005.
119. Kubota, K., Sakikawa, C., Katsumata, M., Nakamura, T., and Wakabayashi, K. Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor. J Bone Miner Res 17, 257, 2002.
120. Hock, J.M., and Canalis, E. Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts. Endocrinology 134, 1423, 1994.
121. Canalis, E., McCarthy, T.L., and Centrella, M. Effects of platelet-derived growth factor on bone formation in vitro. J Cell Physiol 140, 530, 1989.
122. Cochran, D.L., Rouse, C.A., Lynch, S.E., and Graves, D.T. Effects of platelet-derived growth factor isoforms on calcium release from neonatal mouse calvariae. Bone 14, 53, 1993.
123. Lynch, S.E., Trippel, S.B., Finkelman, R.D., Hernandez, R.A., Kiritsy, C.P., and Antoniades, H.N. The combination of platelet-derived growth factor-BB and insulin-like growth factor-I stimulates bone repair in adult Yucatan miniature pigs. Wound Repair Regen 2, 182, 1994.
124. Giannobile, W.V., Finkelman, R.D., and Lynch, S.E. Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. J Periodontol 65, 1158, 1994.
125. Lynch, S.E., Buser, D., Hernandez, R.A., Weber, H.P., Stich, H., Fox, C.H., and Williams, R.C. Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. J Peri-odontol 62, 710, 1991.
126. Lynch, S.E., de Castilla, G.R., Williams, R.C., Kiritsy, C.P., Howell, T.H., Reddy, M.S., and Antoniades, H.N. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 62, 458, 1991.
127. Lynch, S.E., Williams, R.C., Polson, A.M., Howell, T.H., Reddy, M.S., Zappa, U.E., and Antoniades, H.N. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 16, 545, 1989.
128. Howell, T.H., Fiorellini, J.P., Paquette, D.W., Offenbacher, S., Giannobile, W.V., and Lynch, S.E. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 68, 1186, 1997.
129. Giannobile, W.V., Hernandez, R.A., Finkelman, R.D., Ryan, S., Kiritsy, C.P., D'Andrea, M., and Lynch, S.E. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Peri-odontal Res 31, 301, 1996.
130. Boyapati, L., and Wang, H.L. The role of platelet-rich plasma in sinus augmentation: a critical review. Implant Dent 15, 160, 2006.
131. Kitoh, H., Kitakoji, T., Tsuchiya, H., Mitsuyama, H., Na-kamura, H., Katoh, M., and Ishiguro, N. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis-a preliminary result of three cases. Bone 35, 892, 2004.
132. Savarino, L., Cenni, E., Tarabusi, C., Dallari, D., Stagni, C., Cenacchi, A., Fornasari, P.M., Giunti, A., and Baldini, N. Evaluation of bone healing enhancement by lyophilized bone grafts supplemented with platelet gel: a standardized methodology in patients with tibial osteotomy for genu varus. J Biomed Mater Res B Appl Biomater 76, 364, 2006.
133. Simman, R., Hoffmann, A., Bohinc, R.J., Peterson, W.C., and Russ, A.J. Role of platelet-rich plasma in acceleration of bone fracture healing. Ann Plast Surg 61, 337, 2008.
134. Park, E.J., Kim, E.S., Weber, H.P., Wright, R.F., and Mooney, D.J. Improved bone healing by angiogenic factor-enriched platelet-rich plasma and its synergistic enhancement by bone morphogenetic protein-2. Int J Oral Maxillofac Implants 23, 818, 2008.
135. Jung, R.E., Schmoekel, H.G., Zwahlen, R., Kokovic, V., Hammerle, C.H., and Weber, F.E. Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2. Clin Oral Implants Res 16, 676, 2005.
136. Calori, G.M., D'Avino, M., Tagliabue, L., Albisetti, W., d'Imporzano, M., and Peretti, G. An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results. Injury 37 Suppl 3, S43, 2006.
137. Van Den Dolder, J., Mooren, R., Vloon, A.P., Stoelinga, P.J., and Jansen, J.A. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 12, 3067, 2006.
138. Lorenzo, J., Horowitz, M., and Choi, Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29, 403, 2008.
139. Nakashima, T., and Takayanagi, H. The dynamic interplay between osteoclasts and the immune system. Arch Biochem Biophys 473, 166, 2008.
140. Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7, 292, 2007.
141. Weitzmann, M.N., and Pacifici, R. The role of T lymphocytes in bone metabolism. Immunol Rev 208, 154, 2005.
142. Du, X., and Williams, D.A. Interleukin-11: review of molecular, cell biology, and clinical use. Blood 89, 3897, 1997.
143. Du, X.X., and Williams, D.A. Interleukin-11: a multifunctional growth factor derived from the hematopoietic mi-croenvironment. Blood 83, 2023, 1994.
144. Girasole, G., Passeri, G., Jilka, R.L., and Manolagas, S.C. Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 93, 1516, 1994.
145. Hill, P.A., Tumber, A., Papaioannou, S., and Meikle, M.C. The cellular actions of interleukin-11 on bone resorption in vitro. Endocrinology 139, 1564, 1998.
146. Suga, K., Saitoh, M., Fukushima, S., Takahashi, K., Nara, H., Yasuda, S., and Miyata, K. Interleukin-11 induces os-teoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1/2 cells. J Interferon Cytokine Res 21, 695, 2001.
147. Suga, K., Saitoh, M., Kokubo, S., Fukushima, S., Kaku, S., Yasuda, S., and Miyata, K. Interleukin-11 acts synergisti-cally with bone morphogenetic protein-2 to accelerate bone formation in a rat ectopic model. J Interferon Cytokine Res 23, 203, 2003.
148. Suga, K., Saitoh, M., Kokubo, S., Nozaki, K., Fukushima, S., Yasuda, S., Sasamata, M., and Miyata, K. Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model. J Interferon Cytokine Res 24, 343, 2004.
149. Lotinun, S., Sibonga, J.D., and Turner, R.T. Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression. Endocrine 17, 29, 2002.
150. Qin, L., Raggatt, L.J., and Partridge, N.C. Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol Metab 15, 60, 2004.
151. Neer, R.M., Arnaud, C.D., Zanchetta, J.R., Prince, R., Gaich, G.A., Reginster, J.Y., Hodsman, A.B., Eriksen, E.F., Ish-Shalom, S., Genant, H.K., Wang, O., and Mitlak, B.H. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344, 1434, 2001.
152. Dobnig, H., and Turner, R.T. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136, 3632, 1995.
153. Jilka, R.L., Weinstein, R.S., Bellido, T., Roberson, P., Parfitt, A.M.,
154. Leaffer, D., Sweeney, M., Kellerman, L.A., Avnur, Z., Krste-nansky, J.L., Vickery, B.H., and Caulfield, J.P. Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34). Endocrinology 136, 3624, 1995.
155. Onyia, J.E., Bidwell, J., Herring, J., Hulman, J., and Hock, J.M. In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone 17, 479, 1995.
156. Kabasawa, Y., Asahina, I., Gunji, A., and Omura, K. Administration of parathyroid hormone, prostaglandin E2, or 1-alpha,25-dihydroxyvitamin D3 restores the bone inductive activity of rhBMP-2 in aged rats. DNA Cell Biol 22, 541, 2003.
157. Horiuchi, H., Saito, N., Kinoshita, T., Wakabayashi, S., Tsut-sumimoto, T., Otsuru, S., and Takaoka, K. Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline. J Bone Miner Metab 22, 329, 2004.
158. Kempen, D.H.R., Lu, L., Hefferan, T.E., Creemers, L.B., Heijink, A., Maran, A., Dhert, W.J.A., and Yaszemski, M.J. Enhanced BMP-2 induced ectopic and orthotopic bone formation by intermittent PTH(1-34) administration. Tissue Eng A 2010 Jul 28 [Epub ahead of print].
159. Morgan, E.F., Mason, Z.D., Bishop, G., Davis, A.D., Wigner, N.A., Gerstenfeld, L.C., and Einhorn, T.A. Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing. Bone 43, 1031, 2008.
160. Cui, L., Ma, Y.F., Yao, W., Zhou, H., Setterberg, R.B., Liang, T.C., and Jee, W.S. Cancellous bone of aged rats maintains its capacity to respond vigorously to the anabolic effects of prostaglandin E2 by modeling-dependent bone gain. J Bone Miner Metab 19, 29, 2001.
161. Zhou, H., Ma, Y.F., Yao, W., Cui, L., Setterberg, R., Liang, C.T., and Jee, W.S. Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats. Calcif Tissue Int 68, 179, 2001.
162. Montero-Odasso, M., and Duque, G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med 26, 203, 2005.
163. Dawson-Hughes, B., Harris, S.S., Krall, E.A., and Dallal, G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337, 670, 1997.
164. Ooms, M.E., Roos, J.C., Bezemer, P.D., Van Der Vijgh, W.J., Bouter, L.M., and Lips, P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 80, 1052, 1995.
165. Shevde, N.K., Plum, L.A., Clagett-Dame, M., Yamamoto, H., Pike, J.W., and DeLuca, H.F. A potent analog of 1al-pha,25-dihydroxyvitamin D3 selectively induces bone formation. Proc Natl Acad Sci USA 99, 13487, 2002.
166. Ono, I., Tateshita, T., Takita, H., and Kuboki, Y. Promotion of the osteogenetic activity of recombinant human bone morphogenetic protein by basic fibroblast growth factor. J Craniofac Surg 7, 418, 1996.
167. Takita, H., Tsuruga, E., Ono, I., and Kuboki, Y. Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats. Eur J Oral Sci 105, 588, 1997.
168. Vonau, R.L., Bostrom, M.P., Aspenberg, P., and Sams, A.E. Combination of growth factors inhibits bone ingrowth in the bone harvest chamber. Clin Orthop Relat Res 386, 243, 2001.
169. Minamide, A., Yoshida, M., Kawakami, M., Okada, M., Enyo, Y., Hashizume, H., and Boden, S.D. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. Spine 32, 1067, 2007.